ea0022p855 | Thyroid | ECE2010
Vierlinger Klemens
, Noehammer Christa
We aim to distinguish malignant from benign thyroid nodules by their molecular profiles. To this end we employ a range of different genomic and epigenetic technologies such as classical whole genome microarray based transcriptomics, integration and meta analysis of published microarray data, DNA methylation testing and micro-RNA profiling. Our transcriptomics and meta analysis approaches include all major histological entities. The other approaches (DNA methylation and microRN...